[1]
“Preparation and Characterization of a Nanostructured Lipid Carrier-Based Formulation of Pioglitazone for Enhanced Antidiabetic Activity”, Int. J. Environ. Sci., vol. 11, no. 10s, pp. 464–473, Jun. 2025, doi: 10.64252/zpg19n51.